CONTEXT: Patients on investigational clinical trials and their caregivers experience poor quality of life (QOL), which declines as the disease progresses. OBJECTIVE: To examine the effect of a standardized cognitive-behavioral problem-solving educational intervention on the QOL of patients enrolled on investigational clinical trials and their caregivers. DESIGN: Prospective, multi-institution, randomized trial. QOL was measured repeatedly over 6 months. PARTICIPANTS: Patients were simultaneously enrolled onto phase 1, 2, or 3 Institutional Review Board (IRB)-approved cancer clinical trials. INTERVENTION: Intervention arm dyads participated in three conjoint educational sessions during the first month, learning the COPE problem solving model. Nonintervention arm dyads received usual care. OUTCOME MEASURES: Global QOL was measured by the City of Hope Quality of Life Instruments for Patients or Caregivers; problem solving skills were measured by the Social Problem Solving Inventory-Revised. RESULTS: The results are reported using the CONSORT statement. The analytic data set included 476 dyads including 1596 patient data points and 1576 care giver data points. Patient QOL showed no significant difference in the rate of change between the intervention and usual care arms (p = 0.70). Caregiver QOL scores in the intervention arm declined, but at less than half the rate in the control arm (p = 0.02). CONCLUSIONS: The COPE intervention enabled the average caregiver to come much closer to stable QOL over the 6-month follow-up. Future studies should enroll subjects much earlier in the cancer illness trajectory, a common patient/caregiver theme. The maximum effect was seen in caregivers who completed the 6-month follow-up, suggesting that the impact may increase over time.
RCT Entities:
CONTEXT: Patients on investigational clinical trials and their caregivers experience poor quality of life (QOL), which declines as the disease progresses. OBJECTIVE: To examine the effect of a standardized cognitive-behavioral problem-solving educational intervention on the QOL of patients enrolled on investigational clinical trials and their caregivers. DESIGN: Prospective, multi-institution, randomized trial. QOL was measured repeatedly over 6 months. PARTICIPANTS: Patients were simultaneously enrolled onto phase 1, 2, or 3 Institutional Review Board (IRB)-approved cancer clinical trials. INTERVENTION: Intervention arm dyads participated in three conjoint educational sessions during the first month, learning the COPE problem solving model. Nonintervention arm dyads received usual care. OUTCOME MEASURES: Global QOL was measured by the City of Hope Quality of Life Instruments for Patients or Caregivers; problem solving skills were measured by the Social Problem Solving Inventory-Revised. RESULTS: The results are reported using the CONSORT statement. The analytic data set included 476 dyads including 1596 patient data points and 1576 care giver data points. Patient QOL showed no significant difference in the rate of change between the intervention and usual care arms (p = 0.70). Caregiver QOL scores in the intervention arm declined, but at less than half the rate in the control arm (p = 0.02). CONCLUSIONS: The COPE intervention enabled the average caregiver to come much closer to stable QOL over the 6-month follow-up. Future studies should enroll subjects much earlier in the cancer illness trajectory, a common patient/caregiver theme. The maximum effect was seen in caregivers who completed the 6-month follow-up, suggesting that the impact may increase over time.
Authors: Isabelle Boutron; David Moher; Douglas G Altman; Kenneth F Schulz; Philippe Ravaud Journal: Ann Intern Med Date: 2008-02-19 Impact factor: 25.391
Authors: Cindy L Carmack Taylor; Hoda Badr; Ji H Lee; Frank Fossella; Katherine Pisters; Ellen R Gritz; Leslie Schover Journal: Ann Behav Med Date: 2008-09-17
Authors: Jennifer S Temel; Joseph A Greer; Alona Muzikansky; Emily R Gallagher; Sonal Admane; Vicki A Jackson; Constance M Dahlin; Craig D Blinderman; Juliet Jacobsen; William F Pirl; J Andrew Billings; Thomas J Lynch Journal: N Engl J Med Date: 2010-08-19 Impact factor: 91.245
Authors: Joan M Griffin; Laura A Meis; Roderick MacDonald; Nancy Greer; Agnes Jensen; Indulis Rutks; Timothy J Wilt Journal: J Gen Intern Med Date: 2014-05-20 Impact factor: 5.128
Authors: Veerawat Phongtankuel; Lauren Meador; Ronald D Adelman; Jordan Roberts; Charles R Henderson; Sonal S Mehta; Tessa Del Carmen; M C Reid Journal: Am J Hosp Palliat Care Date: 2016-11-10 Impact factor: 2.500
Authors: Nicole S Nevadunsky; Lori Spoozak; Sharon Gordon; Enid Rivera; Kimala Harris; Gary L Goldberg Journal: Int J Gynecol Cancer Date: 2013-03 Impact factor: 3.437
Authors: Brandyn D Lau; Rebecca A Aslakson; Renee F Wilson; Oluwakemi A Fawole; Colleen C Apostol; Kathryn A Martinez; Daniela Vollenweider; Eric B Bass; Sydney E Morss Dy Journal: Am J Hosp Palliat Care Date: 2013-03-26 Impact factor: 2.500